Biing‐Ru Wu

Comparison of the effects of the three major tyrosine kinase inhibitors as first-line therapy for non-small-cell lung cancer harboring epidermal growth factor receptor mutations

Chih‐Yen Tu, Chuan‐Mu Chen, Wei‐Chih Liao et al. · Oncotarget · 2018 · 32 citations · Full text

Medicine, Oncology, Pharmacology +16

The necessity of a loading dose when prescribing intravenous colistin in critically ill patients with CRGNB-associated pneumonia: a multi-center observational study

Sheng‐Huei Wang, Kuang‐Yao Yang, Chau‐Chyun Sheu et al. · Critical Care · 2022 · 16 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +13

Efficacies of Colistin–Carbapenem versus Colistin–Tigecycline in Critically Ill Patients with CR-GNB-Associated Pneumonia: A Multicenter Observational Study

Sheng‐Huei Wang, Kuang‐Yao Yang, Chau‐Chyun Sheu et al. · Antibiotics · 2021 · 14 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +13

Outcomes and Prognostic Factors in Critical Patients with Hematologic Malignancies

Chieh‐Lung Chen, Sing-Ting Wang, Wen‐Chien Cheng et al. · Journal of Clinical Medicine · 2023 · 14 citations · Full text

Medicine, Hematology, Oncology +13

A Real World Study to Assess the Effectiveness of Switching to Once Daily Closed Triple Therapy from Mono/Dual Combination or Open Triple Therapy in Patients with Chronic Obstructive Pulmonary Disease

Wei‐Chun Huang, Chih‐Yu Chen, Wei‐Chih Liao et al. · International Journal of COPD · 2021 · 11 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +14